CurrentlucetPolicy 20.5.007

Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder (Federal Employees)

Customize your policy alerts

Sign up for lucet Policy 20.5.007 alerts

Get alerted when Policy 20.5.007 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy governing medical necessity, coverage criteria, and authorization requirements for ABA treatment of members with Autism Spectrum Disorder under the Federal Employees Service Benefit Plan managed by Lucet Behavioral Health.

Policy Summary

Payerlucet

PolicyApplied Behavior Analysis for the Treatment of Autism Spectrum Disorder (Federal Employees)

Policy CodePolicy 20.5.007

Change TypeRoutine review — no material changes

Effective DateJan 1, 2017

Last ReviewSep 1, 2025

Next Review DateN/A

Key ActionSubmit pre-treatment assessment and authorization requests with DSM-based ASD diagnosis, autism-specific standardized assessment, required baseline data, and a treatment plan meeting Lucet provider and BACB standards.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentlucetPolicy 20.5.007

Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder (Federal Employees)

Customize your policy alerts

Sign up for lucet Policy 20.5.007 alerts

Get alerted when Policy 20.5.007 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

Payerlucet

PolicyApplied Behavior Analysis for the Treatment of Autism Spectrum Disorder (Federal Employees)

Policy CodePolicy 20.5.007

Change TypeRoutine review — no material changes

Effective DateJan 1, 2017

Last ReviewSep 1, 2025

Next Review DateN/A

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

25-40 hrs/wkComprehensive ABA typical weekly direct service range

10-25 hrs/wkFocused ABA typical weekly direct service range

2x/yearTreatment plan review frequency

≤5 years / within 90 daysBaseline data timing requirement

CMO approvalException authority

2017–2025Document history span

Coverage and Medical Necessity Criteria

inv-01: Pre-Treatment Assessment

Covered when ALL of the following are met:

Pre-Treatment Assessment Criteria: 1. The member has a diagnosis of Autism Spectrum Disorder (ASD) based on criteria used in the current DSM, from a licensed clinician; documentation must include a clinical note concordant with DSM criteria and an ASD‑specific standardized assessment. Screening measures alone do not constitute a diagnosis.

Clinicians typically include neurologist, developmental pediatrician, pediatrician, psychiatrist, licensed clinical psychologist, or other medical doctor experienced in ASD diagnosis.

Diagnostic Differential: 2. The comprehensive diagnostic evaluation must rule out other behavior/medical diagnoses with similar presentations (e.g., neurological disorders, hearing disorders, behavior disorders, other developmental delays).

Hours Requested Limitation: 3. Hours requested for the pre‑treatment assessment are no greater than needed to complete the assessment process.

Standards Compliance: 4. All assessment services are provided consistent with the Lucet Provider Manual, the Behavior Analyst Certification Board's Ethics Code (or relevant ethics code), generally accepted standards of care, and applicable state laws.

inv-02: Initial ABA Treatment Authorization

Covered when ALL of the following are met:

Diagnostic Criteria: 1. Diagnostic criteria in the Pre‑Treatment Assessment are met (DSM‑based ASD diagnosis with supporting clinical documentation and ASD‑specific standardized assessment).

Psychological Assessment: 2. Documentation of psychological assessment including autism‑specific testing, adaptive behavior testing, and cognitive/developmental evaluation with a formal report and scores to define baseline functioning.

Baseline Data Timing: 3. Baseline data are completed no more than five (5) years prior to, or scheduled within ninety (90) days of, the pre‑treatment assessment and must include: (a) developmental/cognitive evaluation; (b) autism‑specific assessment identifying severity; (c) adaptive behavior assessment completed within six (6) months of treatment start; and (d) neurological evaluation as part of a comprehensive physical exam.≤ 5 years (or scheduled within 90 days); adaptive behavior ≤ 6 months

inv-03: Continued ABA Treatment Authorization

Covered when ALL of the following are met:

Initial Criteria: 1. Criteria 1–11 from the Initial ABA Treatment Authorization section are met.

Provider Demonstration of Benefit: 2. Provider documents clinical or social benefit from treatment, identifies new or continuing goals, and develops a new or continuing treatment plan based on progress demonstrated by behavioral changes and increased skill acquisition.

Treatments for Autism Spectrum Disorder (ASD) other than Applied Behavior Analysis (ABA) are outside the scope of this medical policy. Examples of non‑ABA approaches listed in the policy include: Cognitive Training, Auditory Integration Therapy, Facilitated Communication, Higashi Schools/Daily Life, Individual Support Program, LEAP, SPELL, Waldon, Hanen, Early Bird, Bright Start, Social Stories, Gentle Teaching, Response Teaching Curriculum, Holding Therapy, Movement Therapy, Music Therapy, Pet Therapy, Psychoanalysis, Son‑Rise Program, Scotopic Sensitivity Training, Sensory Integration Training, and Neurotherapy (EEG biofeedback). Members should consult their Service Benefit Plan to determine whether these non‑ABA treatments are covered under their benefits.

Any request for an exception to the provisions of this medical policy must be reviewed and approved by the Lucet Chief Medical Officer or their designee. Requests without such approval may be denied.

Provider Responsibilities and Authorization Workflow

Prior Authorization

Authorization requirements for pre‑treatment, initial and continued ABA

Pre-treatment assessment and initial and continued ABA authorization requests must include specified diagnostic, assessment, baseline data, treatment plan, setting, provider qualifications, and documentation elements as outlined in policy. Requests must show: (1) an ASD diagnosis per current DSM from a licensed clinician with a clinical note concordant with DSM criteria and an ASD-specific standardized assessment; (2) psychological assessment reports including autism‑specific testing, adaptive behavior testing, and cognitive evaluation with formal scores; (3) required baseline data completed no more than five years prior to or scheduled within 90 days of the pre‑treatment assessment (developmental/cognitive evaluation, autism‑specific severity assessment, adaptive behavior assessment within 6 months of start, and neurological evaluation as part of a physical); (4) treatment goals focused on core ASD symptoms with plans for generalization and caregiver training; and (5) documentation that services are provided consistent with the Lucet Provider Manual and BACB Ethics Code (or relevant ethics code) and that line therapy is provided by appropriately credentialed staff where state law does not specify otherwise.

ASD diagnosis per current DSM with clinical note and ASD‑specific standardized assessment (diagnostic evaluation must rule out similar disorders)
Psychological assessment reports with formal scores (autism‑specific, adaptive behavior, cognitive)
Baseline data: developmental/cognitive eval; autism‑specific severity assessment; adaptive behavior assessment within 6 months of start; neurological evaluation

Key Definitions and Classifications

Functional Behavioral Assessment (FBA) — assessment elements and purpose

DefinitionFunctional Behavioral Assessment (FBA): an assessment including description and history of the problem, antecedent analysis, consequence analysis, and an impression/analysis of the function of the problem.

Assessment elementsIncludes: (a) description of the problem (topography, onset/offset, cycle, intensity, severity); (b) history of the problem (long-term and recent); (c) antecedent analysis (setting, people, time of day, events); (d) consequence analysis; (e) impression and analysis of the function of the problem.

PurposeIdentify core deficits and aberrant behaviors to inform individualized interventions and behavior intervention plans within the treatment plan established during pre-treatment assessment.

Role in treatment planningMay be part of any assessment and used to develop treatment plans that specify designated interventions to address identified deficits and behaviors.

Service Intensity Classification — Comprehensive vs Focused ABA models and typical weekly hours/age ranges

Care Setting and Level of Service

inv-18: Outpatient/Community-based ABA — level-of-care criteria

Outpatient/Community‑based ABA admission and continued stay criteria:

Admission: Member meets diagnostic and assessment requirements (see Pre‑Treatment and Initial Authorization criteria) and has treatment goals appropriate for Comprehensive or Focused ABA as documented in the initial treatment plan.

Admission determination follows model selection and baseline data requirements.

Continued Stay: Provider documents clinical or social benefit and ongoing or updated treatment goals and plan based on progress; documentation must demonstrate that services continue to address active ASD core symptoms or targeted deficits requiring ABA expertise.

Treatment plans are reviewed for medical necessity twice annually.

Discharge Considerations: Treatment discharge is appropriate when goals are met, progress plateaus without further expected benefit, caregiver/alternate plans support generalization, or member no longer meets criteria for medically necessary ABA.

ABA Model-Specific Criteria and Evidence

inv-19: ABA Intensity Models — ABA treatment intensity and model-specific criteria (Comprehensive vs Focused)

ABA treatment intensity and model-specific criteria:

Comprehensive Model: Targets deficits in all core ASD symptoms; requires substantial support, typically 1:1 staffing initially, caregiver training is essential; primarily for children ages 3–8 years. Comprehensive services include individual ABA delivery, caregiver training, supervision, and treatment planning; may include group ABA.25-40 hrs/week

Focused Model: Targets a limited number of behavior goals and emphasizes caregiver training and group work to enhance participation and adaptive skills in the least restrictive environment; used to address prioritized aberrant behaviors with specific Behavior Intervention Plans.10-25 hrs/week

inv-20: Cited evidence — references cited relevant to ABA evidence base and guidelines

References cited relevant to the ABA evidence base and practice guidance:

Treatment Modalities Covered

inv-21: ABA — top-level ABA modality node

Applied Behavior Analysis (ABA) — modality principles and defining features:

ABA Modality Principles: ABA is characterized by applied, behavioral, analytic, technological, and conceptually systematic approaches that aim for effective, generalized outcomes. Interventions are individualized, delivered in structured environments with predictable routines, include caregiver involvement, transition and aftercare planning, and focus on increasing adaptive skills while reducing maladaptive behaviors.

Treatment plans are reviewed twice yearly for medical necessity.

Service Intensity and Visit Limits

Comprehensive ABA direct services — typical direct service range

Direct service rangeComprehensive ABA direct services typically range from 25 to 40 total hours of direct services weekly.

Components includedIncludes ABA delivery to individual recipient, caregiver training, case supervision, and treatment planning; may include group ABA.

Initial staffing and settingShould initially occur in a structured setting with 1:1 staffing and advance to the least restrictive environment as appropriate.

Focused ABA direct services — typical direct service range

Direct service rangeFocused ABA direct services typically range from 10 to 25 total hours of direct services per week.

Components includedMay include individual or group delivery, caregiver training, case supervision, and treatment planning; targets prioritized behavior goals with Behavior Intervention Plan.

Clinical Background

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction across multiple contexts and by restricted, repetitive patterns of behavior, interests, and activities. Per the DSM‑5, these symptoms begin in early development and produce impairment in social, occupational, or other important areas of current functioning. Applied Behavior Analysis (ABA) is the treatment modality addressed in this policy for members with ASD; alternative ASD treatments are not covered by this policy and require Service Benefit Plan consultation for coverage determination.

References and Citation Index

Key references — citations that underpin definitions and standards

NICE surveillance2021 Surveillance of Autism (NICE guidelines CG128, CG142 and CG170).

DSM-5-TRAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.), 2022.

BACB Ethics CodeBehavior Analyst Certification Board. Ethics Code for Behavior Analysts, 2020.

Representative evidence sourcesApplied Behavior Analysis textbooks (Cooper et al., 2020) and key systematic reviews/meta-analyses (Hume et al. 2021; Reichow et al. Cochrane 2018) referenced in policy.

Policy Revision History

Denial Risk

Submit full diagnostic/baseline reports to avoid insufficient‑evidence denials

Document the comprehensive diagnostic evaluation and baseline testing (including formal reports and scores) and submit them with authorization requests to prevent administrative denial for insufficient evidence.

Include ASD-specific standardized assessment results and formal psychological reports for initial authorization ([[chunk 13]]).
Provide adaptive behavior assessment completed within six months of treatment start and other baseline components as specified ([[chunk 13]]).

2025-09RevisionLatest

Clarified baseline data requirements; updated summary of evidence; added 2 references.

Policy Summary

Payerlucet

PolicyApplied Behavior Analysis for the Treatment of Autism Spectrum Disorder (Federal Employees)

Policy CodePolicy 20.5.007

Change TypeRoutine review — no material changes

Effective DateJan 1, 2017

Last ReviewSep 1, 2025

Next Review DateN/A

SourceLink

On This Page

Treatment Focus: 4. Treatment goals and clinical documentation focus on active ASD core symptoms, deficits that inhibit daily functioning, and aberrant behaviors that require the expertise of a Behavior Analyst; goals must include plans for stimulus/response generalization.

Scope Limitations: 5. ABA treatment is not designed to attain academic performance.

Service Distinction: 6. ABA is not a substitute for psychotherapy, occupational therapy, or other medical or behavioral health services.

Care Coordination: 7. Treatment planning includes ongoing coordination of care, safety planning, and discharge planning.

Comprehensive or Focused Goal: 8. Requested services must be consistent with the selected model: either Comprehensive (designed to reduce the developmental–chronological age gap and restore/maximize function) OR Focused (designed to reduce burden of targeted symptoms and increase appropriate alternative behaviors).

Appropriate Setting and Intensity: 9. Treatment is provided in the setting and intensity appropriate to the member's clinical needs (where target behaviors occur and where treatment will impact them).

Provider Qualifications: 10. Treatment provided consistent with the Lucet Provider Manual and BACB Ethics (or relevant ethics code); in the absence of state law, line therapy is provided by an RBT, BCaBA, or Master/Doctoral level BCBA.

Generalization Plan: 11. The treatment plan must include a plan to generalize skills across stimuli, contexts, and people via caregiver training or an appropriate alternative; providers should demonstrate transfer of instructional control to caregivers and identify an alternate plan if caregiver involvement is unsuccessful.

Treatment plan must target active ASD core symptoms, include generalization plan and caregiver training, and coordinate safety and discharge planning

Services must follow Lucet Provider Manual and BACB Ethics; line therapy by RBT/BCaBA/BCBA as applicable

Note

Exceptions require Chief Medical Officer (CMO) approval

Exceptions to this medical policy require explicit approval from the Lucet Chief Medical Officer or the CMO's designee; requests lacking CMO/designee approval may be denied.

Note

Non‑ABA ASD treatments out of scope — consult Service Benefit Plan

Treatments for ASD other than Applied Behavior Analysis (ABA) are outside the scope of this policy. Providers and members should consult the member's Service Benefit Plan to determine coverage for non‑ABA ASD treatment approaches (examples listed in policy include Cognitive Training, Auditory Integration Therapy, Music Therapy, Facilitated Communication, and others).

Non‑ABA approaches listed in policy are not covered under this ABA policy and require Service Benefit Plan consultation for coverage determination

Documentation Required

Submit complete diagnostic and psychological assessment documentation with requests

High‑priority action: ensure diagnostic and assessment documentation accompanies any authorization request — include a clinician's DSM‑based ASD diagnosis, a clinical note demonstrating concordance with DSM criteria, and autism‑specific standardized assessment results; psychological assessment reports with formal scores should be submitted to define baseline functioning.

Clinical note sufficient to demonstrate concordance with current DSM criteria (screening results alone are not sufficient)
Autism‑specific standardized assessment and formal psychological reports with scores

Documentation Required

Required diagnostic and assessment documentation

Diagnostic documentation required for authorization requests must include a DSM‑based diagnosis of ASD from a licensed clinician and a clinical note of sufficient depth demonstrating concordance with DSM core symptom criteria; autism‑specific standardized assessment and psychological reports (autism‑specific testing, adaptive behavior testing, cognitive evaluation) with formal scores are required to define baseline functioning.

Clinicians typically include neurologist, developmental pediatrician, pediatrician, psychiatrist, licensed clinical psychologist, or medical doctor experienced in ASD diagnosis
Assessment reports must include formal scores and detail results

Note

Document history and revision notes — maintain alignment with current policy

Document history entries record the policy's revision timeline and clarifications (for example: clarifications to baseline data requirements and updates to the summary of evidence in 09/2025). Providers should maintain documentation aligned with the current policy revisions and note that the policy has been revised periodically since initial publication in 01/2017.

Recent revision 09/2025: clarified baseline data requirements and updated summary of evidence
Policy entries show annual reviews and revisions by the Chief Medical Officer or Medical Policies Workgroup

Denial Risk

Verify member ABA benefits and meet medical necessity criteria

Coverage for ABA services is available only when the member's benefit plan includes ABA and the medical necessity criteria and guidelines in this policy are met; verification of member benefits is required prior to authorization.

Confirm member contract/certificate includes ABA benefits
Ensure all medical necessity criteria and policy guidelines are documented and met

Prior Authorization

CMO/designee approval required for exceptions

All requests for exceptions or deviations from policy requirements must be approved by the Lucet Chief Medical Officer or their designee before coverage will be authorized.

Lack of CMO/designee approval may result in denial of the request

ModelsTwo service-intensity models: Comprehensive and Focused. Providers should select the model based on pre-treatment assessment findings.

Comprehensive model (typical age range)Primarily for children ages 3–8 years; targets deficits in all core ASD symptoms and includes caregiver training and 1:1 staffing initially.

Comprehensive model (typical weekly hours)Typical direct service range: 25–40 total hours of direct services per week.

Focused model (purpose)Targets a limited number of behavior goals and emphasizes group work and caregiver training to improve participation and adaptive skills.

Focused model (typical weekly hours)Typical direct service range: 10–25 total hours of direct services per week.

Key references — citations that underpin definitions and standards

DSM-5-TRAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.), 2022.

BACB Ethics CodeBehavior Analyst Certification Board. Ethics Code for Behavior Analysts, 2020.

NICE guidance2021 Surveillance of Autism (NICE guidelines CG128, CG142 and CG170), National Institute for Health and Care Excellence, 2021.

Key textbooks and reviewsCooper et al., Applied Behavior Analysis (3rd Ed., 2020) and systematic reviews/meta-analyses (e.g., Hume et al. 2021; Reichow et al. Cochrane 2018) cited in policy.

evidence_sources: Includes NICE surveillance of autism, the DSM‑5‑TR, the Behavior Analyst Certification Board Ethics Code, textbooks on Applied Behavior Analysis, and multiple systematic reviews and meta‑analyses (including Cochrane and Project AIM) and others cited in the references list supporting early intensive behavioral interventions and ABA practices.

References 1–11+ provide the evidence base cited in this policy.

Treatment emphasisEmphasis on group work and caregiver training to enhance participation in family and community life and develop adaptive/social/functional skills.

2024-09Revision

Removed one reference and added a summary of evidence.

2024-01Revision

Updated two references.

2023-09Revision

Document reviewed by Chief Medical Officer.

2022-09Annual Review